Kepler Capital Markets Analysts Give Novartis AG (NOVN) a CHF 88 Price Target

Kepler Capital Markets Analysts Give Novartis AG (NOVN) a CHF 88 Price Target


The firm currently has a buy rating on the stock. NOVN has been the subject of several other reports.



from Biotech News